Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-Compulsive Disorder - Contacts and Locations

Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-Compulsive Disorder

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00389493

Contacts


Contact: Jessica McCarthy, MA	212-543-5380

Contact: Jamie York, BA	215-746-3332

Locations


United States, New York
	New York State Psychiatric Institute	Recruiting
	New York, New York, United States, 10032
	Contact: Jessica McCarthy 212-543-5380
	Contact: Jose Hernandez 212-543-5367
	Principal Investigator: Blair Simpson, MD, PhD
	Sub-Investigator: Michael Liebowitz, MD

United States, Pennsylvania
	University of Pennsylvania Center for the Treatment and Study of Anxiety	Recruiting
	Philadelphia, Pennsylvania, United States, 19104
	Contact: Jamie York, BA 215-746-3332
	Principal Investigator: Edna Foa, PhD
	Sub-Investigator: Shawn Cahill, PhD

Sponsors and Collaborators

National Institute of Mental Health (NIMH)

Investigators


Principal Investigator:	Blair Simpson, MD, PhD	New York State Psychiatric Institute

Principal Investigator:	Edna Foa, PhD	University of Pennsylvania